航宇微(300053.SZ):“珠海一號”星座在軌運行衞星共12顆
格隆匯1月18日丨航宇微(300053.SZ)在投資者關係活動上表示,“珠海一號”衞星星座是由公司發射並運營的商業遙感微納衞星星座,整個星座規劃由34顆遙感衞星組成,目前,“珠海一號”星座在軌運行衞星共12顆,其中視頻衞星4顆、高光譜衞星8顆,是目前我國規模最大、服務能力最強的商業遙感星座之一,其高光譜衞星是目前國內空間分辨率最高、幅寬最大的高光譜衞星,8顆高光譜衞星多軌組網運行,填補了中國商業航天高光譜領域的空白,公司成為全球範圍內擁有高光譜衞星在軌數量最多、高光譜衞星數據服務能力最完善的企業。其特色的高光譜數據具備對植被、水體、農作物等地物進行精準定量分析的能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.